Adenocarcinoma of Colon Terminated Phase 3 Trials for Capecitabine (DB01101)

Also known as: Adenocarcinoma Colon / Colon Adenocarcinoma / Adenocarcinoma of the Colon

IndicationStatusPhase
DBCOND0060083 (Adenocarcinoma of Colon)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00070122
Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal CancerTreatment